Yes, SBRT uses fiducial markers inserted by the therapeutic endoscopist, followed by radiation administered by a specially configured accelerator. The Oncosil product does it all in one, and the same endoscopist who can insert fiducial markers can also inject it. It's a straightforward process, with a low bar to uptake as most EUS endoscopists have the required skills.
OSL Top Pick for FY21, page-11
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.001(10.0%) |
Mkt cap ! $43.51M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $111.8K | 10.17M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 150000 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 7793598 | 12 |
View Market Depth
| Last trade - 11.50am 15/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |